Related Experiment Video
Updated: Jul 9, 2026

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
A Review on Modular Peptide Anchoring Strategies for Functionalizing Liposomal Nanocarriers: Advancing Non-covalent
Adamu Safiyanu Maikifi1, Veerakiet Boonkanokwong2
1Graduate Program of Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Non-covalent peptide insertion offers a simpler method for functionalizing liposomes in targeted cancer drug delivery. This approach enhances liposome stability and manufacturability for improved therapeutic outcomes.
Area of Science:
- Nanomedicine
- Drug Delivery Systems
- Cancer Therapeutics
Background:
- Liposomes are versatile drug carriers for targeted cancer therapy.
- Conventional liposome functionalization uses covalent ligand attachment, which can be complex and impact ligand activity.
- Non-covalent peptide insertion presents a simpler, adaptable alternative for liposome modification.
Purpose of the Study:
- To review non-covalent peptide-liposome interactions for targeted drug delivery.
- To analyze mechanisms, incorporation techniques, and therapeutic applications.
- To provide formulation guidance for stability, manufacturability, and clinical translation.
Main Methods:
- Focus on non-covalent peptide insertion into liposomal membranes.
- Analysis of hydrophobic and electrostatic interaction mechanisms.
- Evaluation of formulation-relevant criteria and comparative strategies.
Main Results:
- Non-covalent methods offer advantages in simplicity and adaptability over covalent approaches.
- Key formulation criteria include stability, manufacturability, and clinical translatability.
- Manufacturing, quality control, and regulatory aspects are critical for clinical success.
Conclusions:
- Non-covalent peptide-liposome interactions are a promising strategy for advanced drug delivery systems.
- This review offers decision frameworks for optimizing liposome formulation for cancer therapy.
- Addressing manufacturing and regulatory challenges is essential for clinical translation.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
